title: Coupling of posterior cytoskeletal morphogenesis to the G1/S transition in the Trypanosoma brucei cell cycle.
abstract: The expression levels of four Cdc2-related kinases (CRK1, 2, 4, and 6) in the procyclic form of Trypanosoma brucei were knocked down in pairs using the RNA interference (RNAi) technique. A double knockdown of CRK1 and CRK2 resulted in arrested cell growth in the G1 phase accompanied by an apparent cessation of nuclear DNA synthesis. The arrested cells became elongated at the posterior end like the G1-phase cells generated by knockdown of CycE1/CYC2 in a previous study. However, approximately 5% of the G1 cells in the current study also possessed multiply branched posterior ends, which have not previously been observed in T. brucei. DAPI and immunofluorescence staining showed a single nucleus, kinetoplast, basal body, and flagellum in the anterior portion of each G1 cell. The split and grossly extended posterior ends were heavily stained with antibodies to tyrosinated alpha-tubulin, suggesting an accumulation of newly synthesized microtubules. A significant population of anucleate cells (zoids), apparently derived from kinetoplast-dictated cytokinesis and cell division of the G1 cells, also had extended and branched posterior ends filled with newly synthesized microtubules. This continued posterior extension of microtubules in the G1 cells and zoids suggests that CRK1 and CRK2 exert a coordinated control on G1/S passage and the limited growth of the microtubule corset toward the posterior end. This connection may provide a new insight into the mechanism of morphological maintenance of an ancient protist during its cell cycle progression.
authors.affiliation: Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143-2280, USA.
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Tu
authors.forename: Ching C
authors.initials: CC
authors.lastname: Wang
mesh_terms: D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002453:Cell Cycle; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D002469:Cell Separation; D004396:Coloring Agents / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D018076:DNA, Complementary / Q000378:metabolism; D018105:DNA, Kinetoplast / Q000378:metabolism; D018450:Disease Progression; D005407:Flagella / Q000378:metabolism; D005434:Flow Cytometry; D016193:G1 Phase; D007211:Indoles / Q000494:pharmacology; D008856:Microscopy, Fluorescence; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016196:S Phase; D013997:Time Factors; D014346:Trypanosoma brucei brucei; D014404:Tubulin / Q000378:metabolism
chemical_list: D004396:Coloring Agents; D018076:DNA, Complementary; D018105:DNA, Kinetoplast; D007211:Indoles; D014404:Tubulin; C007293:DAPI; D004247:DNA; D001973:Bromodeoxyuridine